In July 2017 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the weightlifter Raúl Arturo Ladrón de Guevara after his sample tested positive for the prohibited substances 19-norandrosterone, 19-noretiocholanolone (Nandrolone), Stanozolol and Tamoxifen.

After notification a provisional suspension was ordered. The Athlete failed to file a statement in his defece nor did he appear for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).
Without the Athlete's response and considering the test results the Panel concludes that the Athlete committed the anti-doping rule violation.

Therefore on 15 December 2017 the TED Disciplinary Panel decides to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. 17 July 2017.

In August 2017 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the weightlifter Jorge Alfredo Fuentes Calfuñanco after his sample tested positive for the prohibited substance Octopamine.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete admitted the intentional use of the substance and stated that the product was provided by another athlete. As a result he also resigned als leader of his sporting club.

Therefore on 15 December 2017 the TED Disciplinary Panel decides to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. 14 August 2017.

In December 2017 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the fencer Karen Valeska Moreno Soto for her failure to submit to sample collection.

The Doping Control Officer (DCO) reported that during training on 12 December 2017 the Athlete was notified to provide a sample. Five other athletes provided a sample after training without issues. However that evening the Athlete failed to appear at the doping control station. She already had left home and she didn't respond to the phone calls of the DCO.

A provisional suspension was ordered, the Athlete filed a statement with evidence in her defence and she was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete acknowledged that she was notified and denied she intentionally evaded the doping control. She explained that after fencing training she saw no DCO and she went to another room. When she later returned to the fencing room that evening she saw nobody anymore and left. Only on her way home she noticed the missed phone calls of the DCO.

Hereafter the CNCD indicated it was not possible anymore to provide a sample. Instead she produced the (negative) analysis results of her sample she provided voluntarily and tested by the drugs abuse laboratory of the University of Chile.

The Panel holds that the Athlete was properly notified that she was selected for doping control. The Panel does not accept that she forgot to appear for doping control. Considering the evidence, the Athlete's conduct and her degree of fault in this case the Panel concludes that the violation was not intentional and that there are grounds for a reduced sanction.

Therefore on 1 March 2018 the TED Disciplinary Panel decides to impose a 18 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. 12 December 2017.

In November 2017 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the canoeist Jeannaret Jazmin Valenzuela Soto after her sample tested positive for the prohibited substance Meldonium.

After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she did not attend the hearing of the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete requested to set aside the test results and contested the charges. The Athlete asserted that several irregularities occurred during the sample collection procedure as ground for invalidate the test results. She argued that she underwent not an official doping control as she was told that the sample collection was intended for sample analysis for the requirement for the accreditation process of the Doping Laboratory of the University of Chile. As a result when notified of the violation she became aware that she indeed underwent an official doping test. Finally she complained that the confidentiality was breached due to the CNCD had already issued a press release to the media about the alleged violation.

The Panel finds that the Athlete failed to provide evidence in support of her assertions, nor did she explain how the substance entered her system. The Panel holds that the violation was not intentional as the CNCD did not provide evidence to the contrary.

Therefore on 6 March 2018 the TED Disciplinary Panel rejectes the Athletes arguments and assertions and decides to impose a 2 year period of ineligibility on the Athlete.

In March 2018 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the minor tennis player after her sample tested positive for the prohibited substance Canrenone.

After notification a provisional suspension was ordered. The Minor Athlete filed a statement in her defence and she was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete's parents requested to set aside the allegations against their daughter. They contended that the Athlete's medication provided by her doctor and pharmacy could not be the source of the positive test as the medication was checked for prohibited substances. Also the substance Canrenone is not available in Chile.

The Panel holds that the Athlete's parents didn't provide evidence in support of their allegations and arguments. The Panel finds that the violation was not intentional as the CNCD did not provide evidence to the contrary.

The Panel considers that Minor Athlete was inexperienced, had not received anti-doping education and that the substance in question does not enhance sport performance for establishing No Significant Fault or Negligence.

Therefore on 6 June 2018 the TED Disciplinary Panel decides to impose a 6 month period of ineligibility on the Minor Athlete starting on the date of the provisional suspension, i.e. on 6 March 2018.

In January 2018 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the Athlete Sebastian Andre Valdivia Floresafter his sample tested positive for the prohibited substances 19-norandrosterone and 19-noretiocholanolone (Nandrolone).

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Athlete accepted the test results, admitted the violation, denied the intentional use of the substances.
He assumed that his consumption of meat or his use of the product Tribulus Terrestris testosterone booster might have caused the positive test results. He argued that he was tested before without issues and didn't have the resources to buy expensive substances as Nandrolone.

The Panel finds that the Athlete failed to provide evidence in support of his arguments and assertions. Also the Panel considers that he admitted the violation and gave an explanation how the substance entered his system.

Therefore on 6 June 2018 the TED Disciplinary Panel decides to impose a 30 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 25 January 2018.

In October 2019 the National Doping Control Commission of Chile (CNCD) has reported an anti-doping rule violation against the football player Matias Sepulveda Méndez for tampering with any part of doping control.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Disciplinary Panel of the Tribunal de Expertos en Dopaje (TED).

The Doping Control Officer (DCO) reported that on 1 September 2019 after notification the player did not report to the Doping Control Station straight from the pitch as soon as the match was over. Instead he went into a dressing room and stayed there, without supervision of the DCO, for 5 to 10 minutes behind a closed door. Hereafter the Athlete complied and he was submitted to sample collection.

The Athlete denied the violation, requested for a reduced sanction and asserted that over the years he was tested before without issues. He testified with evidence that after the notification he went to the dressing room to get his identity card. Yet, the team coach entered, closed the door of the dressing room and gave technical instructions to his team regarding the match. Thereupon he immediately went to the Doping Control Station.

Based on the evidence in this case the Panel established that the Athlete indeed failed to report immediately to the Doping Control Station. However because of the circumstances the Panel concludes that he acted without significant fault or negligence.

Therefore the TED Disciplinary Panel decides on 5 May 2020 to impose a warning on the Athlete.

Telmisartan as metabolic modulator: a new perspective in sports doping? / Favian Sanchis-Gomar and Giuseppe Lippi. – In: Journal of Strength and Conditioning Research, 3 (2012), vol. 26 (March), p. 608-610

The World Antidoping Agency (WADA) has introduced some changes in the 2012 prohibited list. Among the leading innovations to the rules are that both 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (peroxisome proliferator-activated receptor-δ [PPAR-δ]-5' adenosine monophosphate-activated protein kinase [AMPK] agonist) and GW1516 (PPAR-δ-agonist) are no longer categorized as gene doping substances in the new 2012 prohibited list but as metabolic modulators in the class "Hormone and metabolic modulators." This may also be valid for the angotensin II receptor blocker telmisartan. It has recently been shown that telmisartan might induce similar biochemical, biological, and metabolic changes (e.g., mitochondrial biogenesis and changes in skeletal muscle fiber type) as those reported for the former call of substances. We suspect that metabolic modulators abuse such as telmisartan might become a tangible threat in sports and should be thereby targeted as an important antidoping issue. The 2012 WADA prohibited list does not provide telmisartan for a potential doping drug, but arguments supporting the consideration to include them among "metabolic modulators" are at hand.

Testing conditional superannuation as an anti-doping policy supplement for safeguarding athlete health and welfare / Liam J.A.Lenten, Aaron C.T. Smith. - (Performance Enhancement & Health 7 (2020) 3-4 (March); p. 1-4)

• DOI: 10.1016/j.peh.2020.100159

Abstract

Given the significant, adverse health implications associated with performance-enhancing drugs in sport, anti-doping policy represents a pivotal intervention for not only protecting sport’s credibility, but also for safeguarding athletes’ health. However, current World Anti-doping Agency (WADA) policy has proven limited in controlling banned doping. This letter reports on a pilot experimental economics study testing ‘conditional superannuation’ as a novel anti-doping policy. A conditional superannuation policy compels athletes to direct a nominal percentage of their sport-related earnings into a managed fund, and only returned to athletes after a period of retirement. Results demonstrate that the policy outperforms existing penalties such as fines and bans. With sport’s hyper-competitive, commercial values, it remains improbable that an elite sports world will ever fully eliminate drugs. Nevertheless, sport needs regulation to help protect athletes from the health costs that arise from uncontrolled substance use. As existing penalty mechanisms appear to be inadequate for controlling sport doping, this letter recommends further research into conditional superannuation as a supplementary anti-doping policy to assist in safeguarding athlete health and welfare by lowering the incentive to utilize banned substances. The policy may also have applications to further domains of health including hospitals, allied health services, and aged care.

Testing for GW501516 (cardarine) in human hair using LC/MS–MS and confirmation by LC/HRMS / Pascal Kintz, Alice Ameline, Laurie Gheddar, Jean‐Sébastien Raul. - 
(Drug Testing and Analysis 12 (2020) 7 (July); p. 980-986)

• PMID: 32298044
• DOI: 10.1002/dta.2802

Abstract

GW501516, also known as GW‐1516 or cardarine and endurobol, is a peroxisome proliferator‐activated receptor delta (PPAR‐δ) agonist. Activation of the receptor will increase fat‐burning capacity and muscle production, as it changes the body's fuel preference from glucose to lipids. GW501516 has no therapeutic use, but can be abused for performance‐enhancing purposes using the oral route, at dosages of 10 to 20 mg per day, for 6 to 8 weeks. Both athletes and amateurs can abuse GW501516 as the drug can be easily obtained via the Internet. Since January 2009, the list of prohibited substances and methods of doping as established by the World Anti‐Doping Agency includes GW‐501516, first as a gene doping substance and now in the S4.5 Metabolic modulators class. It is prohibited at all times. Using LC/MS–MS and confirmation by LC/HRM, after methanol incubation of 20 mg with ultrasound for 1 hour, GW501516 was identified in the hair of a male abuser at 32 and 22 pg/mg in 2 × 2 cm segments. The result is the first evidence that this compound with a carboxylic acid function is incorporated in human hair.